Insmed Incorporated

NasdaqGS:INSM 주식 보고서

시가총액: US$11.0b

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Insmed 관리

관리 기준 확인 3/4

Insmed's CEO는 Will Lewis, Sep2012 에 임명되었습니다 의 임기는 11.75 년입니다. 총 연간 보상은 $ 10.41M, 7.5% 로 구성됩니다. 7.5% 급여 및 92.5% 보너스(회사 주식 및 옵션 포함). 는 $ 29.48M 가치에 해당하는 회사 주식의 0.28% 직접 소유합니다. 29.48M. 경영진과 이사회의 평균 재임 기간은 각각 4.6 년과 10.1 년입니다.

주요 정보

Will Lewis

최고 경영자

US$10.4m

총 보상

CEO 급여 비율7.5%
CEO 임기11.8yrs
CEO 소유권0.3%
경영진 평균 재임 기간4.6yrs
이사회 평균 재임 기간10.1yrs

최근 관리 업데이트

Recent updates

Insmed Incorporated's (NASDAQ:INSM) 92% Share Price Surge Not Quite Adding Up

May 29
Insmed Incorporated's (NASDAQ:INSM) 92% Share Price Surge Not Quite Adding Up

Insmed Strikes Gold With Phase 3 Bronchiectasis Win (Rating Upgrade)

May 28

Insmed Incorporated (NASDAQ:INSM) Just Released Its Yearly Results And Analysts Are Updating Their Estimates

Feb 25
Insmed Incorporated (NASDAQ:INSM) Just Released Its Yearly Results And Analysts Are Updating Their Estimates

Insmed Incorporated (NASDAQ:INSM) Investors Are Less Pessimistic Than Expected

Dec 18
Insmed Incorporated (NASDAQ:INSM) Investors Are Less Pessimistic Than Expected

Getting In Cheap On Insmed Incorporated (NASDAQ:INSM) Is Unlikely

Jul 28
Getting In Cheap On Insmed Incorporated (NASDAQ:INSM) Is Unlikely

Calculating The Intrinsic Value Of Insmed Incorporated (NASDAQ:INSM)

Jul 01
Calculating The Intrinsic Value Of Insmed Incorporated (NASDAQ:INSM)

Would Insmed (NASDAQ:INSM) Be Better Off With Less Debt?

Apr 18
Would Insmed (NASDAQ:INSM) Be Better Off With Less Debt?

A Look At The Fair Value Of Insmed Incorporated (NASDAQ:INSM)

Feb 23
A Look At The Fair Value Of Insmed Incorporated (NASDAQ:INSM)

Insmed inks financing agreements to raise $500M

Oct 19

Does Insmed (NASDAQ:INSM) Have A Healthy Balance Sheet?

Oct 17
Does Insmed (NASDAQ:INSM) Have A Healthy Balance Sheet?

An Intrinsic Calculation For Insmed Incorporated (NASDAQ:INSM) Suggests It's 46% Undervalued

Sep 20
An Intrinsic Calculation For Insmed Incorporated (NASDAQ:INSM) Suggests It's 46% Undervalued

Insmed rises 16% on better-than-expected Q2 result

Aug 04

Is Insmed (NASDAQ:INSM) A Risky Investment?

Jun 24
Is Insmed (NASDAQ:INSM) A Risky Investment?

Insmed: Temporarily Stuck

Feb 19

Is Insmed (NASDAQ:INSM) Using Debt Sensibly?

Dec 11
Is Insmed (NASDAQ:INSM) Using Debt Sensibly?

CEO 보상 분석

Will Lewis 의 보수는 Insmed 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Mar 31 2024n/an/a

-US$747m

Dec 31 2023US$10mUS$780k

-US$750m

Sep 30 2023n/an/a

-US$724m

Jun 30 2023n/an/a

-US$696m

Mar 31 2023n/an/a

-US$547m

Dec 31 2022US$8mUS$735k

-US$482m

Sep 30 2022n/an/a

-US$434m

Jun 30 2022n/an/a

-US$416m

Mar 31 2022n/an/a

-US$438m

Dec 31 2021US$7mUS$710k

-US$435m

Sep 30 2021n/an/a

-US$424m

Jun 30 2021n/an/a

-US$375m

Mar 31 2021n/an/a

-US$319m

Dec 31 2020US$6mUS$660k

-US$294m

Sep 30 2020n/an/a

-US$245m

Jun 30 2020n/an/a

-US$242m

Mar 31 2020n/an/a

-US$247m

Dec 31 2019US$7mUS$641k

-US$254m

Sep 30 2019n/an/a

-US$293m

Jun 30 2019n/an/a

-US$320m

Mar 31 2019n/an/a

-US$330m

Dec 31 2018US$6mUS$610k

-US$324m

Sep 30 2018n/an/a

-US$298m

Jun 30 2018n/an/a

-US$256m

Mar 31 2018n/an/a

-US$224m

Dec 31 2017US$4mUS$567k

-US$193m

보상 대 시장: Will 의 총 보상 ($USD 10.41M )은 US 시장에서 비슷한 규모의 회사의 평균 수준입니다( $USD 13.50M ).

보상과 수익: 회사가 수익성이 없는 동안 Will 의 보상이 증가했습니다.

CEO

Will Lewis (55 yo)

11.8yrs

테뉴어

US$10,411,260

보상

Mr. William H. Lewis, also known as Will, J.D. M.B.A. serves as an Independent Chairman of Board of Directors of NewAmsterdam Pharma Company N.V. from January 2024. He has been Chief Executive Officer and...

리더십 팀

이름위치테뉴어보상소유권
William Lewis
President11.8yrsUS$10.41m0.28%
$ 30.6m
Sara Bonstein
Chief Financial Officer4.4yrsUS$4.56m0.011%
$ 1.2m
Roger Adsett
Chief Operating Officer4.6yrsUS$4.01m0.039%
$ 4.3m
John Wise
Chief Commercial Officer4.6yrsUS$3.89m0.032%
$ 3.5m
Martina Flammer
Chief Medical Officer4.5yrsUS$4.22m0.0079%
$ 863.8k
Brian Kaspar
Chief Scientific Officerno data데이터 없음데이터 없음
Eleanor Barisser
Associate Director of Investor Relationsno data데이터 없음데이터 없음
Michael Smith
Chief Legal Officer & Corporate Secretary2.9yrs데이터 없음0.055%
$ 6.0m
Mandy Fahey
Executive Director of Corporate Communicationsno data데이터 없음데이터 없음
S. Schaeffer
Chief People Strategy Officer11.4yrsUS$2.66m0.027%
$ 2.9m
Eugene Sullivan
Chief Product Strategy Officer7.1yrsUS$1.69m데이터 없음
Neil Hughes
GM & Head of Europe5yrs데이터 없음데이터 없음

4.6yrs

평균 재임 기간

55yo

평균 연령

경험이 풍부한 관리: INSM 의 관리팀은 경험 ( 4.6 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름위치테뉴어보상소유권
William Lewis
President11.8yrsUS$10.41m0.28%
$ 30.6m
David W. McGirr
Independent Director10.7yrsUS$320.00k0.053%
$ 5.8m
Melvin Sharoky
Independent Director23.1yrsUS$312.50k0.21%
$ 22.8m
Alfred Altomari
Independent Director11.8yrsUS$320.00k0.035%
$ 3.8m
David Brennan
Lead Independent Director10.1yrsUS$345.00k0.067%
$ 7.4m
Clarissa Desjardins
Independent Director4.6yrsUS$315.00k0.030%
$ 3.3m
Elizabeth Anderson
Independent Director5.6yrsUS$310.00k0.034%
$ 3.8m
Leo Lee
Independent Director6.1yrsUS$317.50k0.069%
$ 7.6m
Carol Schafer
Independent Director4.2yrsUS$315.00k0.028%
$ 3.1m

10.1yrs

평균 재임 기간

65yo

평균 연령

경험이 풍부한 이사회: INSM 의 이사회는 노련하고 경험이 있습니다(평균 재직 기간 10.1 년).